logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Foundation Medicine, Inc.


USPTO Granted Patents = 47



Trademarks = 26

Forward Citations = 410

Loading Chart...
Loading Chart...

76 inventors (with patents filed for the assignee):

goldMedal Philip James Stephens (26 out of 27 patents)

silverMedal Roman Yelensky (25 out of 34 patents)

bronzeMedal Doron Lipson (24 out of 35 patents)

4.  Matthew J Hawryluk (17 out of 17 patents)

5.  Garrett Michael Frampton (12 out of 12 patents)

6.  Vincent A Miller (11 out of 11 patents)

7.  Geoffrey Alan Otto (9 out of 20 patents)

8.  Alexander Nevin Parker (9 out of 9 patents)

9.  Sean R Downing (8 out of 9 patents)

10.  Jeffrey S Ross (7 out of 34 patents)

11.  David Fabrizio (7 out of 7 patents)

12.  James Xin Sun (7 out of 9 patents)

13.  Gary Palmer (7 out of 8 patents)

14.  Maureen T Cronin (6 out of 6 patents)

15.  Jie He (6 out of 6 patents)


Core Competencies:
Fusion Molecules
Genomic Alterations
Cancer Prognosis
Multigene Analysis
Therapeutic Methods
Diagnostic Methods
Genetic Variants
Cholangiocarcinoma
Estrogen Receptor Mutations
NTRK1
ALK
Patient Outcomes

47 patents:

1. 12692548 - BCOR REARRANGEMENTS AND USES THEREOF (2026-07-28),
2. 12649952 - NTRK fusion molecules and uses thereof (2026-06-09),
3. 12584163 - COMPOSITIONS AND METHODS FOR EVALUATING GENOMIC ALTERATIONS (2026-03-24),
4. 12559800 - KMT2A-MAML2 FUSION MOLECULES AND USES THEREOF (2026-02-24),
5. 12555690 - Tree-based model for selecting treatments and determining expected treatment outcomes (2026-02-17),
6. 12548682 - System and method for outcome tracking and analysis (2026-02-10),
7. 12522873 - NOVEL ALK AND NTRK1 FUSION MOLECULES AND USES THEREOF (2026-01-13),
8. 12473589 - COMPOSITIONS AND METHODS FOR EVALUATING GENOMIC ALTERATIONS (2025-11-18),
9. 12456541 - Analysis of genetic variants (2025-10-28),
10. 12378302 - Fusion molecules and uses thereof (2025-08-05),
11. 12334192 - Computer-implemented system and method for identifying similar patients (2025-06-17),
12. 12331128 - Therapeutic and diagnostic methods for cancer (2025-06-17),
13. 12274699 - Methods of treating cholangiocarcinoma (2025-04-14),
14. 12239648 - KIF5B-RET fusion molecules and uses thereof (2025-03-04),
15. 12180540 - Optimization of multigene analysis of tumor samples (2024-12-31),
Company Overview
Foundation Medicine, Inc. is a leader in precision medicine, specializing in genomic profiling to inform cancer treatment decisions. The company develops advanced diagnostic solutions that analyze the molecular characteristics of tumors, enabling personalized therapeutic strategies. Based in Cambridge, MA, Foundation Medicine collaborates with healthcare providers and researchers to enhance patient outcomes through innovative technologies and comprehensive genomic insights, ultimately aiming to transform cancer care and improve survival rates.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Foundation Medicine, Inc. USPTO Patent Assignee Logo
47 Patents

#56 in Cambridge, MA

#416 in Massachusetts

#7,430 in US

#14,803 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Foundation Medicine, Inc.

Forward Citations = 410

76 inventors:

goldMedal Philip James Stephens (26 out of 27 patents)

silverMedal Roman Yelensky (25 out of 34 patents)

bronzeMedal Doron Lipson (24 out of 35 patents)

4.  Matthew J Hawryluk (17 out of 17 patents)

5.  Garrett Michael Frampton (12 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Foundation Medicine, Inc.. Retrieved from https://idiyas.com/company/foundation-medicine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…